MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

Meeting: 2019 International Congress

Abstract Number: 1542

Keywords: Cognitive dysfunction, Olfactory dysfunction, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease.

Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period and the variable manifestations of its cardinal motor symptoms. Since non-motor symptoms precede the onset of motor symptoms, they are gaining more attention both to aid diagnosis and to more fully understand the underlying disease mechanisms. In particular, the presence of olfactory dysfunction is currently used as a non-disease-specific diagnostic aid for Parkinson’s disease, as substantial olfactory dysfunction can occur before the onset of motor symptoms. However, the underlying causes and mechanisms involved in olfactory dysfunction are incompletely understood.

Method: Relationships between olfactory dysfunction and cognitive assessments were evaluated using for 1,280 subjects assigned by the Parkinson’s Progression Marker’s Initiative (PPMI) into different Parkinson’s-disease diagnostic categories. Structural equation modeling was used to evaluate whether impaired global cognition (measured by the Montreal Cognitive Assessment), verbal learning and memory (measured by a Hopkins Verbal Learning Test subscore), and visuospatial/executive functioning (measured as a Montreal Cognitive Assessment subscore) each contribute to olfactory dysfunction (measured by the University of Pennsylvania Smell Identification Test score) in these diagnostic categories.

Results: When measures of global cognition and verbal learning/memory were included in the same model, only the measure of verbal learning/memory was significant in explaining olfactory dysfunction. However, when the measure of global cognition was replaced by a measure of visuospatial/executive function, it too was significant in explaining olfactory dysfunction for some of the PPMI diagnostic categories.

Conclusion: Impairment of the cognitive processes associated with verbal learning/memory and visuospatial/executive function contribute to the olfactory dysfunction seen in Parkinson’s disease.

To cite this abstract in AMA style:

B. Chase, A. Mertens, J. Santo, K. Markopoulou. Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-processes-that-indirectly-effect-olfactory-dysfunction-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-processes-that-indirectly-effect-olfactory-dysfunction-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley